BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gadekar V, Borade Y, Kannaujia S, Rajpoot K, Anup N, Tambe V, Kalia K, Tekade RK. Nanomedicines accessible in the market for clinical interventions. Journal of Controlled Release 2021;330:372-97. [DOI: 10.1016/j.jconrel.2020.12.034] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 54.0] [Reference Citation Analysis]
Number Citing Articles
1 Losada-barreiro S, Sezgin-bayindir Z, Paiva-martins F, Bravo-díaz C. Biochemistry of Antioxidants: Mechanisms and Pharmaceutical Applications. Biomedicines 2022;10:3051. [DOI: 10.3390/biomedicines10123051] [Reference Citation Analysis]
2 Li J, Zhu L, Kwok HF. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100904] [Reference Citation Analysis]
3 Katopodi T, Petanidis S, Tsavlis D, Anestakis D, Charalampidis C, Chatziprodromidou I, Eskitzis P, Zarogoulidis P, Kosmidis C, Matthaios D, Porpodis K. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy. Front Oncol 2022;12:1042125. [DOI: 10.3389/fonc.2022.1042125] [Reference Citation Analysis]
4 Liu W, Ma X, Kheyr SM, Dong A, Zhang J. Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents. Materials (Basel) 2022;15:7215. [PMID: 36295281 DOI: 10.3390/ma15207215] [Reference Citation Analysis]
5 Kalyane D, Choudhary D, Polaka S, Goykar H, Karanwad T, Rajpoot K, Kumar Tekade R. Reactive oxygen nano-generators for cancer therapy. Progress in Materials Science 2022;130:100974. [DOI: 10.1016/j.pmatsci.2022.100974] [Reference Citation Analysis]
6 Grifoni L, Vanti G, Donato R, Sacco C, Bilia AR. Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities. Molecules 2022;27:6070. [PMID: 36144803 DOI: 10.3390/molecules27186070] [Reference Citation Analysis]
7 Patil P, Nene S, Shah S, Singh SB, Srivastava S. Exploration of novel drug delivery systems in topical management of osteoarthritis. Drug Deliv and Transl Res . [DOI: 10.1007/s13346-022-01229-z] [Reference Citation Analysis]
8 Dovnar RI, Vasil'kov AY, Dovnar IS, Iaskevich NN. Wound Healing on Application of Natural and Synthetic Polymer Materials with Silver Nanoparticles. Macromolecular Symposia 2022;404:2100337. [DOI: 10.1002/masy.202100337] [Reference Citation Analysis]
9 Das M, Joshi A, Devkar R, Seshadri S, Thakore S. Tumor homing dextran and curcumin derived amphiphilic functional polymer self-assembling to tubustecan nanoarchitectures: A strategy of adorning the golden spice (curcumin) for taming the red devil (Dox). Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103666] [Reference Citation Analysis]
10 Cai Y, Qi J, Lu Y, He H, Wu W. The in vivo fate of polymeric micelles. Adv Drug Deliv Rev 2022;:114463. [PMID: 35905947 DOI: 10.1016/j.addr.2022.114463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gupta U, Saren BN, Khaparkhuntikar K, Madan J, Singh PK. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer. J Control Release 2022;348:1089-115. [PMID: 35640765 DOI: 10.1016/j.jconrel.2022.05.034] [Reference Citation Analysis]
12 Sainaga Jyothi VGS, Bulusu R, Venkata Krishna Rao B, Pranothi M, Banda S, Kumar Bolla P, Kommineni N. Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update. Int J Pharm 2022;624:122022. [PMID: 35843364 DOI: 10.1016/j.ijpharm.2022.122022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Tambe V, Patel S, Shard A, Behera SK, Polaka S, Anup N, Gadeval A, Kalia K, Tekade RK. Dendronized Polymeric Biomaterial for Loading, Stabilization, and Targeted Cytosolic Delivery of microRNA in Cancer Cells. ACS Appl Bio Mater . [DOI: 10.1021/acsabm.2c00179] [Reference Citation Analysis]
14 Aydin E, Aydin A, Çetiner G, Akbaba H, Erel Akbaba G. DOĞADAN İLHAM BİYOMİMETİK NANOTAŞIYICI SİSTEMLER. Ankara Universitesi Eczacilik Fakultesi Dergisi 2022. [DOI: 10.33483/jfpau.1033286] [Reference Citation Analysis]
15 Fan W, Peng H, Yu Z, Wang L, He H, Ma Y, Qi J, Lu Y, Wu W. The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers. Acta Pharm Sin B 2022;12:2479-93. [PMID: 35646531 DOI: 10.1016/j.apsb.2021.11.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Shete MB, Patil TS, Deshpande AS, Saraogi G, Vasdev N, Deshpande M, Rajpoot K, Tekade RK. Current trends in theranostic nanomedicines. Journal of Drug Delivery Science and Technology 2022;71:103280. [DOI: 10.1016/j.jddst.2022.103280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 He S, Gui J, Xiong K, Chen M, Gao H, Fu Y. A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases. J Nanobiotechnology 2022;20:101. [PMID: 35241085 DOI: 10.1186/s12951-022-01307-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Polaka S, Makwana V, Vasdev N, Sheth A, Rajpoot K, Sengupta P, Tekade RK. Engineering immunity via skin-directed drug delivery devices. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
20 Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules 2022;27:1372. [PMID: 35209162 DOI: 10.3390/molecules27041372] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
21 Rapozzi V, Moret F, Menilli L, Guerrini A, Tedesco D, Naldi M, Bartolini M, Gani M, Zorzet S, Columbaro M, Milani C, Martini C, Ferroni C, Varchi G. HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer. Cancers (Basel) 2022;14:877. [PMID: 35205627 DOI: 10.3390/cancers14040877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Bikiaris R, Christodoulou E, Kostoglou M, Kasimatis M, Iatrou H, Nikolaidis N. Paliperidone palmitate depot microspheres based on biocompatible poly(alkylene succinate) polyesters as long-acting injectable formulations. Journal of Drug Delivery Science and Technology 2022;68:103056. [DOI: 10.1016/j.jddst.2021.103056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Huang L, Yang J, Wang T, Gao J, Xu D. Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01257-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Fang F, Yuan Y, Wan Y, Li J, Song Y, Chen WC, Zhao D, Chi Y, Li M, Lee CS, Zhang J. Near-Infrared Thermally Activated Delayed Fluorescence Nanoparticle: A Metal-Free Photosensitizer for Two-Photon-Activated Photodynamic Therapy at the Cell and Small Animal Levels. Small 2022;18:e2106215. [PMID: 35018711 DOI: 10.1002/smll.202106215] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
25 Yu J, Mu Q, Fung M, Xu X, Zhu L, Ho RJY. Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response. Pharmacol Ther 2022;236:108108. [PMID: 34999182 DOI: 10.1016/j.pharmthera.2022.108108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
26 Parikh KJ, Christian JR, Rajpoot K, Tekade RK. Environmental and safety aspects of bionanotechnology. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00022-6] [Reference Citation Analysis]
27 Asati S, Pandey V, Gour V, Tiwari R, Soni V, Rajpoot K, Tekade M, Sharma MC, Tekade RK. Toxicity and toxicokinetic considerations in product development and drug research. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00001-9] [Reference Citation Analysis]
28 Tiwari A, Joshi M, Salvi N, Gupta D, Gandhi S, Rajpoot K, Tekade RK. Toxicity of pharmaceutical azo dyes. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00004-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Rajpoot K, Desai N, Koppisetti H, Tekade M, Sharma MC, Behera SK, Tekade RK. In silico methods for the prediction of drug toxicity. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00012-3] [Reference Citation Analysis]
30 Arafa KK, El-sherbiny IM. Polymeric micelles with cleavable links for drug delivery. Polymeric Micelles for Drug Delivery 2022. [DOI: 10.1016/b978-0-323-89868-3.00020-3] [Reference Citation Analysis]
31 Huang Q, Liu X, Wang H, Liu X, Zhang Q, Li K, Chen Y, Zhu Q, Shen Y, Sui M. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer. Acta Biomater 2022;137:262-75. [PMID: 34718178 DOI: 10.1016/j.actbio.2021.10.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Polaka S, Koppisetti HP, Satvase R, Manchikalapudi AL, Tekade M, Sharma MC, Tekade RK. Molecular biology of apoptotic, necrotic, and necroptotic cell death. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00027-5] [Reference Citation Analysis]
33 Polaka S, Vasdev N, Raji S, Makwana V, Rajput A, Kulkarni M, Tekade M, Pingale P, Sharma MC, Tekade RK. Toxicogenomics in drug safety assessment. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00005-6] [Reference Citation Analysis]
34 Gupta R, Polaka S, Rajpoot K, Tekade M, Sharma MC, Tekade RK. Importance of toxicity testing in drug discovery and research. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00016-0] [Reference Citation Analysis]
35 Gupta R, Rajpoot K, Tekade M, Sharma MC, Safavi M, Tekade RK. Factors influencing drug toxicity. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00014-7] [Reference Citation Analysis]
36 Parhizkar M, Tsaoulidis D. The Outlook for Novel Pharmaceutics. Future of Business and Finance 2022. [DOI: 10.1007/978-3-030-99838-7_16] [Reference Citation Analysis]
37 Pandey V, Polaka S, Nalla LV, Tekade M, Sharma MC, Tekade RK. Excipient toxicity and safety. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00025-1] [Reference Citation Analysis]
38 Tabarzad M, Mohit E, Ghorbani-bidkorbeh F. Nanovaccines delivery approaches against infectious diseases. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00002-6] [Reference Citation Analysis]
39 Gupta R, Rajpoot K, Tekade M, Sharma MC, Tekade RK. Methods and models for in vitro toxicity. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00006-8] [Reference Citation Analysis]
40 Rajpoot K, Tekade M, Sharma MC, Arafat B, Tekade RK. Principles and concepts in toxicokinetic. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00023-8] [Reference Citation Analysis]
41 Polaka S, Tella JD, Tekade M, Sharma MC, Tekade RK. Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00008-1] [Reference Citation Analysis]
42 Rajpoot K, Katare P, Tekade M, Sharma MC, Polaka S, Sengupta P, Tekade RK. Toxicokinetic and toxicodynamic considerations in drug research. Pharmacokinetics and Toxicokinetic Considerations 2022. [DOI: 10.1016/b978-0-323-98367-9.00026-3] [Reference Citation Analysis]
43 Zhu R, Lang T, Yin Q, Li Y. Nano drug delivery systems improve metastatic breast cancer therapy. Medical Review 2021;1:244-274. [DOI: 10.1515/mr-2021-0011] [Reference Citation Analysis]
44 Niu B, Liao K, Zhou Y, Wen T, Quan G, Wu C, Pan X. Cellular defense system-destroying nanoparticles as a platform for enhanced chemotherapy against drug-resistant cancer. Mater Sci Eng C Mater Biol Appl 2021;131:112494. [PMID: 34857280 DOI: 10.1016/j.msec.2021.112494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Franconi F, Lemaire L, Gimel JC, Bonnet S, Saulnier P. NMR diffusometry: A new perspective for nanomedicine exploration. J Control Release 2021;337:155-67. [PMID: 34280413 DOI: 10.1016/j.jconrel.2021.07.025] [Reference Citation Analysis]
46 Tan JYB, Yoon BK, Cho NJ, Lovrić J, Jug M, Jackman JA. Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides. Int J Mol Sci 2021;22:9664. [PMID: 34575831 DOI: 10.3390/ijms22189664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
47 Ilangala AB, Lechanteur A, Fillet M, Piel G. Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems. Eur J Pharm Biopharm 2021;167:140-58. [PMID: 34311093 DOI: 10.1016/j.ejpb.2021.07.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
48 Ditani AS, Mallick PP, Anup N, Tambe V, Polaka S, Sengupta P, Rajpoot K, Tekade RK. Biosimilars accessible in the market for the treatment of cancer. J Control Release 2021;336:112-29. [PMID: 34126171 DOI: 10.1016/j.jconrel.2021.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
49 Bondarenko O, Saarma M. Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain. Front Cell Neurosci 2021;15:682597. [PMID: 34149364 DOI: 10.3389/fncel.2021.682597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
50 Romero EL, Morilla MJ. Preclinical autophagy modulatory nanomedicines: big challenges, slow advances. Expert Opin Drug Deliv 2021;:1-19. [PMID: 34030559 DOI: 10.1080/17425247.2021.1933428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Biswas N, Abu Ammar A, Frušić-Zlotkin M, Adi-Hen N, Lehman-Katabi Y, Levi-Kalisman Y, Nassar T, Benita S. Biodistribution and efficacy of the anticancer drug, oxaliplatin palmitate acetate, in mice. Int J Pharm 2021;604:120740. [PMID: 34062232 DOI: 10.1016/j.ijpharm.2021.120740] [Reference Citation Analysis]
52 Cauzzo J, Jayakumar N, Ahluwalia BS, Ahmad A, Škalko-Basnet N. Characterization of Liposomes Using Quantitative Phase Microscopy (QPM). Pharmaceutics 2021;13:590. [PMID: 33919040 DOI: 10.3390/pharmaceutics13050590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
53 Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cantù L, Nicoli S. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release 2021;332:312-36. [PMID: 33652113 DOI: 10.1016/j.jconrel.2021.02.031] [Cited by in Crossref: 117] [Cited by in F6Publishing: 131] [Article Influence: 117.0] [Reference Citation Analysis]
54 Yang Y, Fan Z, Zheng K, Shi D, Su G, Ge D, Zhao Q, Fu X, Hou Z. A novel self-targeting theranostic nanoplatform for photoacoustic imaging-monitored and enhanced chemo-sonodynamic therapy. J Mater Chem B 2021;9:5547-59. [PMID: 34165487 DOI: 10.1039/d1tb01025e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Tambe V, Shukla H, Rajpoot K, Pandey MM, Tekade RK. Pharmacokinetics aspects of biotechnological products. Biopharmaceutics and Pharmacokinetics Considerations 2021. [DOI: 10.1016/b978-0-12-814425-1.00012-7] [Reference Citation Analysis]